Dimension Capital I, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share (GLUE)

Filing Manager: Dimension Capital I, L.P.
Reporting Manager: Adam Goulburn
Security: Monte Rosa Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: GLUE
Shares outstanding: 65,095,000 shares
Disclosed Ownership: 5,663,265 shares
Ownership: 8.7%
Form type: SCHEDULE 13G/A
Filing time: 21 Jan 2026, 11:59:07 UTC
Date of event: 31 Dec 2025
Previous filing: 03 Oct 2025
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Adam Goulburn	8.7%	5,663,265	5,663,265	/s/ Adam Goulburn	Adam Goulburn
Zavain Dar	8.7%	5,663,265	5,663,265	/s/ Zavain Dar	Zavain Dar
Nan Li	8.7%	5,663,265	5,663,265	/s/ Nan Li	Nan Li
Dimension Management, L.P.	8.7%	5,663,265	5,663,265	/s/ Adam Goulburn	By: Dimension Management GP, LLC, its general partne; By: Adam Goulburn, Member
Dimension Capital I GP, LLC	8.7%	5,663,265	5,663,265	/s/ Adam Goulburn	Adam Goulburn, Member
Dimension Management GP, LLC	8.7%	5,663,265	5,663,265	/s/ Adam Goulburn	Adam Goulburn, Member
Dimension Capital I, L.P.	8.7%	5,663,265	5,663,265	/s/ Adam Goulburn	By: Dimension Capital I GP, LP, its general partner; By: Adam Goulburn, Member